Ginsenoside Rg1 promotes the efficacy of human amnion-derived mesenchymal stem cells in alleviating chemotherapy-induced premature ovarian insufficiency in rats
Rg1 may promote the efficacy of hAD-MSC transplantation in alleviating chemotherapy-induced POI in rats. Rg1 might be a novel adjuvant drug to promote the efficacy of MSCs in the treatment of chemotherapy-induced POI.
Authors
- Caijiao Peng
- Yubin Huang (ORCID: https://orcid.org/0000-0001-7577-2062)
- Qianru Zeng (ORCID: https://orcid.org/0009-0007-7323-7331)
- Li Ling (ORCID: https://orcid.org/0000-0002-9387-8802)
- Jie Zeng (ORCID: https://orcid.org/0000-0001-8809-888X)
- Lanhua Wu
Institutions
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Journal of Ovarian Research
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1186/s13048-025-01886-x
- Primary Topic
- Reproductive Biology and Fertility
- Type
- article
- Field-Weighted Citation Impact
- 0.00